Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 21 Nov 2020)

 

Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial
It is widely acknowledged that HPV prophylactic vaccine could prevent new infections and their associated lesions among women who are predominantly HPV-naive at vaccination. Yet there still remains uncertainty…
Authors: Shuang Zhao, Shangying Hu, Xiaoqian Xu, Xun Zhang, Qinjing Pan, Feng Chen and Fanghui Zhao
Citation: BMC Infectious Diseases 2020 20:846
Content type: Research article
Published on: 16 November 2020